Page last updated: 2024-08-17

ethinyl estradiol and fibrinopeptide a

ethinyl estradiol has been researched along with fibrinopeptide a in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19903 (50.00)18.7374
1990's3 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atsma, WJ; Fioretti, P; Fruzzetti, F; Lammers, P; Melis, GB; Nicoletti, I; Ricci, C1
Cerri, M; Fioretti, P; Fruzzetti, F; Melis, GB; Miccoli, R; Navalesi, R; Orlandi, MC; Ricci, C1
Carmassi, F; Fioretti, P; Fruzzetti, F; Melis, GB; Ricci, C1
Carmassi, F; Fioretti, P; Fruzzetti, F; Melis, GB; Paoletti, AM1
Fioretti, P; Fruzzetti, F; Ricci, C1
Angioni, S; Deiana, P; Genazzani, AR; Grasso, A; Mauri, A; Silferi, M; Volpe, A1

Trials

1 trial(s) available for ethinyl estradiol and fibrinopeptide a

ArticleYear
A comparative study on the effects of a monophasic pill containing desogestrel plus 20 micrograms ethinylestradiol, a triphasic combination containing levonorgestrel and a monophasic combination containing gestodene on coagulatory factors.
    Contraception, 1991, Volume: 43, Issue:1

    Topics: Adult; Analysis of Variance; Blood Coagulation Factors; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinopeptide A; Humans; Levonorgestrel; Longitudinal Studies; Norgestrel; Norpregnenes; Progesterone Congeners; Random Allocation

1991

Other Studies

5 other study(ies) available for ethinyl estradiol and fibrinopeptide a

ArticleYear
Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel.
    Contraception, 1987, Volume: 35, Issue:3

    Topics: Adult; Blood Glucose; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Hormonal; Desogestrel; Ethinyl Estradiol; Female; Fibrinopeptide A; Humans; Insulin; Lipids; Menstrual Cycle; Norpregnenes; Time Factors

1987
Oral contraceptives and venous thromboembolic disease: the effect of the oestrogen dose.
    Maturitas, 1988, Volume: Suppl 1

    Topics: Contraceptives, Oral, Hormonal; Estrogens; Ethinyl Estradiol; Female; Fibrinopeptide A; Humans; Risk; Thromboembolism

1988
Fibrinopeptide A plasma levels during low-estrogen oral contraceptive treatment.
    Contraception, 1984, Volume: 30, Issue:6

    Topics: Adolescent; Adult; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinogen; Fibrinopeptide A; Humans; Menstrual Cycle; Norpregnenes; Radioimmunoassay

1984
Haemostasis profile in smoking and nonsmoking women taking low-dose oral contraceptives.
    Contraception, 1994, Volume: 49, Issue:6

    Topics: Adolescent; Adult; Antithrombin III; Contraceptives, Oral; Ethinyl Estradiol; Female; Fibrinogen; Fibrinopeptide A; Hemostasis; Humans; Middle Aged; Prothrombin Time; Smoking

1994
Efficacy on hyperandrogenism and safety of a new oral contraceptive biphasic formulation containing desogestrel.
    European journal of obstetrics, gynecology, and reproductive biology, 1994, Mar-15, Volume: 53, Issue:3

    Topics: Acne Vulgaris; Adolescent; Adult; Apolipoproteins A; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Fibrinopeptide A; Humans; Hyperandrogenism; Sex Hormone-Binding Globulin

1994